Most Raised HealthTech Deal | 20/20 Surpasses $3M

Click to rate this post!
[Total: 0 Your Rating: 0]

20/20 GeneSystems, most raised live healthtech deal, surpasses $3M & closing next week

We are excited to announce that 20/20 has surpassed $3M raised, making it the healthtech company with the most investments currently on SeedInvest.

20/20 is developing and commercializing artificial intelligence-powered diagnostics for cancer & COVID-19. The company recently announced it will sell the first & only FDA-authorized COVID-19 rapid antibody test for point-of-care use.

The last day to invest in 20/20 on SeedInvest is Friday, October 30th – 11 days from today.


Join Our Newsletter



By Registering, you agree that you've read and accepted our disclaimer, you're at least 18 years old, you consent to the terms presented on the disclaimer, and to receive notifications from us.